Randall A. Lipps - Mar 14, 2025 Form 4 Insider Report for OMNICELL, INC. (OMCL)

Role
CHAIRMAN, PRESIDENT AND CEO, Director
Signature
/s/ Vijay Biligiri, Attorney in Fact for Randall A Lipps
Stock symbol
OMCL
Transactions as of
Mar 14, 2025
Transactions value $
$349,874
Form type
4
Date filed
3/18/2025, 04:13 PM
Previous filing
Mar 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMCL Common Stock Purchase $350K +10.6K +3.27% $33.13 334K Mar 14, 2025 Direct F3
transaction OMCL Common Stock Award $0 +79.5K +23.83% $0.00 413K Mar 15, 2025 Direct F4
holding OMCL Common Stock 356K Mar 14, 2025 In Trust with Wife F1
holding OMCL Common Stock 8.05K Mar 14, 2025 In Trust for Children F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held in trust with Mr. Lipps' wife.
F2 Shares held in trust for the benefit of Mr. Lipps' children.
F3 The price reported in Column 4 is a weighted average price of $33.1289 The purchase price range between $32.745 to $33.44 The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on March 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15.